- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 317/22 - SulfonesSulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
Patent holdings for IPC class C07C 317/22
Total number of patents in this class: 260
10-year publication summary
18
|
26
|
15
|
19
|
12
|
21
|
13
|
14
|
19
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Peloton Therapeutics, Inc. | 37 |
12 |
Baylor College of Medicine | 941 |
8 |
Kumiai Chemical Industry Co., Ltd. | 312 |
8 |
Integrative Research Laboratories Sweden AB | 33 |
6 |
The Regents of the University of California | 19839 |
5 |
Sumitomo Chemical Company, Limited | 9018 |
5 |
Arcus Biosciences, Inc. | 134 |
5 |
Nippon Soda Co., Ltd. | 891 |
5 |
The University of British Columbia | 1495 |
5 |
Bristol-myers Squibb Company | 4875 |
4 |
AstraZeneca AB | 2933 |
4 |
Canopy Growth Corporation | 219 |
4 |
DIC Corporation | 3759 |
4 |
Ishihara Sangyo Kaisha, Ltd. | 658 |
4 |
Mcmaster University | 795 |
4 |
National University Corporation, Iwate University | 89 |
4 |
Novartis AG | 10883 |
3 |
AstraZeneca UK Limited | 655 |
3 |
ExxonMobil Research And Engineering Company | 2590 |
3 |
Toray Industries, Inc. | 6906 |
3 |
Other owners | 161 |